This could signify that clinically well APOE E2 individuals exhibit a signature similar to insulin resistance as compared to E3, which may be supported by APOE E2’s association with increased DAGs, especially in older individuals, discussed earlier. This evidence concerns the gene APOE and Insulin resistance.